X0306 4 2020-06-23 0001682852 Moderna, Inc. MRNA 0001760669 Hoge Stephen C/O MODERNA, INC. 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 1 President Common Stock 2020-06-23 4 S 0 3009 63.34 D 1983531 D Common Stock 2020-06-23 4 S 0 1891 64.19 D 1981640 D Common Stock 2020-06-23 4 S 0 100 64.95 D 1981540 D Common Stock 2020-06-24 4 S 0 2205 64.33 D 1979335 D Common Stock 2020-06-24 4 S 0 2595 65.11 D 1976740 D Common Stock 2020-06-24 4 S 0 200 65.84 D 1976540 D Common Stock 4116 I By Valhalla, LLC This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.86 to $63.81. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.87 to $64.81. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.70 to $64.70. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.72 to $65.54. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.78 to $65.90. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. /s/ Lori Henderson, as Attorney-in-Fact 2020-06-25